In line with this, we demonstrated that l-lactate treatment in ESCC cells shifts PAS usage toward more distal sites, particularly within FDX1, and depletion of NUDT21 abolishes the effect of l-lactate on FDX1 3′ UTR lengthening. The gene discussed is FDX1; the disease is esophageal squamous cell carcinoma.